vs
Adeia Inc.（ADEA）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Adeia Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$104.8M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 19.5%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 9.5%）
Adeia Inc.是一家全球化知识产权授权与创新企业，主营半导体制造、消费电子、媒体分发及智能设备领域的专利技术研发与商业化合作，与全球多家头部科技企业达成授权合作，推动相关行业技术升级。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ADEA vs PBYI — 直观对比
营收规模更大
ADEA
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出8.2%
19.5%
两年增速更快
PBYI
近两年复合增速
9.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.8M | $75.5M |
| 净利润 | $22.8M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 33.2% | 22.7% |
| 净利率 | 21.7% | — |
| 营收同比 | 19.5% | 27.7% |
| 净利润同比 | 92.8% | — |
| 每股收益（稀释后） | $0.20 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADEAPBYI
| Q1 26 | $104.8M | — | ||
| Q4 25 | $182.6M | $75.5M | ||
| Q3 25 | $87.3M | $54.5M | ||
| Q2 25 | $85.7M | $52.4M | ||
| Q1 25 | $87.7M | $46.0M | ||
| Q4 24 | $119.2M | $59.1M | ||
| Q3 24 | $86.1M | $80.5M | ||
| Q2 24 | $87.3M | $47.1M |
净利润ADEAPBYI
| Q1 26 | $22.8M | — | ||
| Q4 25 | $73.7M | — | ||
| Q3 25 | $8.8M | $8.8M | ||
| Q2 25 | $16.7M | $5.9M | ||
| Q1 25 | $11.8M | $3.0M | ||
| Q4 24 | $36.0M | — | ||
| Q3 24 | $19.3M | $20.3M | ||
| Q2 24 | $8.4M | $-4.5M |
毛利率ADEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率ADEAPBYI
| Q1 26 | 33.2% | — | ||
| Q4 25 | 59.5% | 22.7% | ||
| Q3 25 | 30.9% | 17.6% | ||
| Q2 25 | 19.1% | 12.7% | ||
| Q1 25 | 26.0% | 8.7% | ||
| Q4 24 | 48.2% | 22.6% | ||
| Q3 24 | 32.7% | 27.4% | ||
| Q2 24 | 27.1% | -4.6% |
净利率ADEAPBYI
| Q1 26 | 21.7% | — | ||
| Q4 25 | 40.4% | — | ||
| Q3 25 | 10.1% | 16.2% | ||
| Q2 25 | 19.5% | 11.2% | ||
| Q1 25 | 13.5% | 6.5% | ||
| Q4 24 | 30.2% | — | ||
| Q3 24 | 22.4% | 25.2% | ||
| Q2 24 | 9.6% | -9.6% |
每股收益（稀释后）ADEAPBYI
| Q1 26 | $0.20 | — | ||
| Q4 25 | $0.66 | $0.26 | ||
| Q3 25 | $0.08 | $0.17 | ||
| Q2 25 | $0.15 | $0.12 | ||
| Q1 25 | $0.10 | $0.06 | ||
| Q4 24 | $0.32 | $0.40 | ||
| Q3 24 | $0.17 | $0.41 | ||
| Q2 24 | $0.07 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.3M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | — | $130.3M |
| 总资产 | $1.0B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ADEAPBYI
| Q1 26 | $53.3M | — | ||
| Q4 25 | $136.7M | $97.5M | ||
| Q3 25 | $115.1M | $94.4M | ||
| Q2 25 | $116.5M | $96.0M | ||
| Q1 25 | $116.5M | $93.2M | ||
| Q4 24 | $110.4M | $101.0M | ||
| Q3 24 | $89.2M | $96.7M | ||
| Q2 24 | $94.5M | $96.8M |
总债务ADEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | $418.5M | $22.7M | ||
| Q3 25 | $438.7M | $34.0M | ||
| Q2 25 | $448.9M | $45.3M | ||
| Q1 25 | $459.2M | $56.7M | ||
| Q4 24 | $475.5M | $68.0M | ||
| Q3 24 | $524.4M | $79.3M | ||
| Q2 24 | $535.6M | $90.7M |
股东权益ADEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | $480.5M | $130.3M | ||
| Q3 25 | $413.7M | $115.3M | ||
| Q2 25 | $402.9M | $104.7M | ||
| Q1 25 | $389.5M | $97.1M | ||
| Q4 24 | $396.6M | $92.1M | ||
| Q3 24 | $378.2M | $71.1M | ||
| Q2 24 | $359.1M | $48.5M |
总资产ADEAPBYI
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $216.3M | ||
| Q3 25 | $1.1B | $202.9M | ||
| Q2 25 | $1.1B | $194.9M | ||
| Q1 25 | $1.1B | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.1B | $205.0M |
负债/权益比ADEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.87× | 0.17× | ||
| Q3 25 | 1.06× | 0.30× | ||
| Q2 25 | 1.11× | 0.43× | ||
| Q1 25 | 1.18× | 0.58× | ||
| Q4 24 | 1.20× | 0.74× | ||
| Q3 24 | 1.39× | 1.12× | ||
| Q2 24 | 1.49× | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 2.57× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ADEAPBYI
| Q1 26 | $58.5M | — | ||
| Q4 25 | $60.0M | $14.4M | ||
| Q3 25 | $17.8M | $9.7M | ||
| Q2 25 | $23.1M | $14.1M | ||
| Q1 25 | $57.1M | $3.6M | ||
| Q4 24 | $107.5M | $15.6M | ||
| Q3 24 | $14.3M | $11.0M | ||
| Q2 24 | $23.5M | $1.0M |
自由现金流ADEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | $59.4M | $14.4M | ||
| Q3 25 | $17.0M | $9.7M | ||
| Q2 25 | $22.9M | $14.1M | ||
| Q1 25 | $56.9M | $3.6M | ||
| Q4 24 | $106.9M | $15.6M | ||
| Q3 24 | $14.3M | $11.0M | ||
| Q2 24 | $23.0M | $1.0M |
自由现金流率ADEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | 32.5% | 19.1% | ||
| Q3 25 | 19.5% | 17.7% | ||
| Q2 25 | 26.7% | 26.8% | ||
| Q1 25 | 64.9% | 7.7% | ||
| Q4 24 | 89.7% | 26.4% | ||
| Q3 24 | 16.6% | 13.7% | ||
| Q2 24 | 26.4% | 2.1% |
资本支出强度ADEAPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.9% | 0.0% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 0.5% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.5% | 0.0% |
现金转化率ADEAPBYI
| Q1 26 | 2.57× | — | ||
| Q4 25 | 0.81× | — | ||
| Q3 25 | 2.02× | 1.10× | ||
| Q2 25 | 1.38× | 2.41× | ||
| Q1 25 | 4.84× | 1.21× | ||
| Q4 24 | 2.98× | — | ||
| Q3 24 | 0.74× | 0.54× | ||
| Q2 24 | 2.80× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
